| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Farha Bilal Motiwala, Kim Stasia Siscoe, Rif S El-Mallak. Review of depot aripiprazole for schizophrenia. Patient preference and adherence. vol 7. 2013-11-22. PMID:24265550. |
a new depot aripiprazole formulation for the treatment of schizophrenia will be available soon. |
2013-11-22 |
2023-08-12 |
Not clear |
| Farha Bilal Motiwala, Kim Stasia Siscoe, Rif S El-Mallak. Review of depot aripiprazole for schizophrenia. Patient preference and adherence. vol 7. 2013-11-22. PMID:24265550. |
depot aripiprazole appears to be both safe and effective in the long-term treatment of schizophrenia. |
2013-11-22 |
2023-08-12 |
Not clear |
| David N Osser, Mohsen Jalali Roudsari, Theo Manschrec. The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia. Harvard review of psychiatry. vol 21. issue 1. 2013-10-29. PMID:23656760. |
the first-line treatment recommendation for new-onset schizophrenia is with amisulpride, aripiprazole, risperidone, or ziprasidone for four to six weeks. |
2013-10-29 |
2023-08-12 |
Not clear |
| Shigenori Tadokor. [Aripiprazole as "dopamine sensitivity stabilizer"]. Nihon rinsho. Japanese journal of clinical medicine. vol 71. issue 4. 2013-09-25. PMID:23678600. |
aripiprazole (ari) is one of atypical antipsychotics used for the treatment of schizophrenia all over the world, owing to its tolerability and ability to keep antipsychotic effect for an extended period of time. |
2013-09-25 |
2023-08-12 |
Not clear |
| Long-acting injectable aripiprazole (Abilify Maintena) for schizophrenia. The Medical letter on drugs and therapeutics. vol 55. issue 1415. 2013-09-25. PMID:23836344. |
long-acting injectable aripiprazole (abilify maintena) for schizophrenia. |
2013-09-25 |
2023-08-12 |
Not clear |
| Bong Ju Lee, Seung Ju Lee, Min Kyung Kim, Jung Goo Lee, Sung Woo Park, Gyung Mee Kim, Young Hoon Ki. Effect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidone. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 11. issue 2. 2013-09-11. PMID:24023549. |
effect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidone. |
2013-09-11 |
2023-08-12 |
Not clear |
| Bong Ju Lee, Seung Ju Lee, Min Kyung Kim, Jung Goo Lee, Sung Woo Park, Gyung Mee Kim, Young Hoon Ki. Effect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidone. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 11. issue 2. 2013-09-11. PMID:24023549. |
this study aimed to assess the efficacy of aripiprazole for the management of cognitive impairments and hyperprolactinemia in patients with schizophrenia on a stable dose of risperidone. |
2013-09-11 |
2023-08-12 |
Not clear |
| Yutaro Suzuki, Takuro Sugai, Naoki Fukui, Junzo Watanabe, Shin Ono, Nobuto Tsuneyama, Mami Saito, Toshiyuki Somey. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics. Schizophrenia research. vol 145. issue 1-3. 2013-09-10. PMID:23375624. |
we examined the differences in plasma prl levels among 268 patients treated for schizophrenia with olanzapine (olz), risperidone (ris), aripiprazole (arp), quetiapine (qtp), or perospirone (per). |
2013-09-10 |
2023-08-12 |
human |
| Frederike Schirmbeck, Franziska Rausch, Susanne Englisch, Sarah Eifler, Christine Esslinger, Andreas Meyer-Lindenberg, Mathias Zin. Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study. Journal of psychopharmacology (Oxford, England). vol 27. issue 4. 2013-09-09. PMID:23095245. |
over 12 months, we followed-up 75 schizophrenia patients who were classified into two groups according to antipsychotic treatment: clozapine or olanzapine (group i) versus aripiprazole or amisulpride (group ii). |
2013-09-09 |
2023-08-12 |
Not clear |
| Ganesh Gopalakrishna, Arpit Aggarwal, John Lauriell. Long-acting injectable aripiprazole: how might it fit in our tool box? Clinical schizophrenia & related psychoses. vol 7. issue 2. 2013-09-05. PMID:23644169. |
long-acting injectable aripiprazole was approved for the treatment of schizophrenia by the u.s. fda on 28th february 2013 and will be marketed under the name abilify maintena. |
2013-09-05 |
2023-08-12 |
Not clear |
| Johan Lataster, Inez Myin-Germeys, Marieke Wichers, Philippe A E G Delespaul, J van Os, Maarten Ba. Psychotic exacerbation and emotional dampening in the daily life of patients with schizophrenia switched to aripiprazole therapy: a collection of standardized case reports. Therapeutic advances in psychopharmacology. vol 1. issue 5. 2013-08-28. PMID:23983939. |
psychotic exacerbation and emotional dampening in the daily life of patients with schizophrenia switched to aripiprazole therapy: a collection of standardized case reports. |
2013-08-28 |
2023-08-12 |
Not clear |
| Domingo Gonzalez, Markus Bienroth, Vivienne Curtis, Matthew Debenham, Stuart Jones, Didier Pitsi, Mohan Georg. Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current medical research and opinion. vol 29. issue 3. 2013-08-09. PMID:23323879. |
consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. |
2013-08-09 |
2023-08-12 |
Not clear |
| Domingo Gonzalez, Markus Bienroth, Vivienne Curtis, Matthew Debenham, Stuart Jones, Didier Pitsi, Mohan Georg. Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Current medical research and opinion. vol 29. issue 3. 2013-08-09. PMID:23323879. |
of the available agents for rt, aripiprazole demonstrated a favourable efficacy and safety profile both over the short-term - including in its intramuscular form (im) - and in the long-term treatment of bipolar i disorder and schizophrenia. |
2013-08-09 |
2023-08-12 |
Not clear |
| X Fan, C P C Borba, P Copeland, D Hayden, O Freudenreich, D C Goff, D C Henderso. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta psychiatrica Scandinavica. vol 127. issue 3. 2013-07-30. PMID:22943577. |
metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. |
2013-07-30 |
2023-08-12 |
Not clear |
| X Fan, C P C Borba, P Copeland, D Hayden, O Freudenreich, D C Goff, D C Henderso. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta psychiatrica Scandinavica. vol 127. issue 3. 2013-07-30. PMID:22943577. |
this study examined the effects of adjunctive aripiprazole therapy on metabolism in clozapine-treated patients with schizophrenia. |
2013-07-30 |
2023-08-12 |
Not clear |
| Silvio Cacci. Safety and pharmacokinetics of atypical antipsychotics in children and adolescents. Paediatric drugs. vol 15. issue 3. 2013-07-30. PMID:23588704. |
recent controlled trials have demonstrated the efficacy of some of these agents (including aripiprazole, clozapine, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone) in adolescent schizophrenia and children or adolescent bipolar mania, or to treat severe aggression and self-injury in the context of autism in children and adolescents. |
2013-07-30 |
2023-08-12 |
Not clear |
| K C Jindal, Gurvinder Pal Singh, Vivek Munja. Aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical study from India. International journal of psychiatry in clinical practice. vol 17. issue 1. 2013-07-22. PMID:22339214. |
aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical study from india. |
2013-07-22 |
2023-08-12 |
Not clear |
| K C Jindal, Gurvinder Pal Singh, Vivek Munja. Aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical study from India. International journal of psychiatry in clinical practice. vol 17. issue 1. 2013-07-22. PMID:22339214. |
the aim of the study was to compare efficacy and tolerability of aripiprazole with olanzapine in the short-term treatment of schizophrenia in an indian population. |
2013-07-22 |
2023-08-12 |
Not clear |
| E E Tsukarz. [Efficacy of aripiprazole (amdoal) in the long-term treatment of schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 113. issue 3. 2013-07-18. PMID:23755402. |
[efficacy of aripiprazole (amdoal) in the long-term treatment of schizophrenia]. |
2013-07-18 |
2023-08-12 |
Not clear |
| Zhenhe Zhou, Hongmei Zhu, Lin Che. Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia. PloS one. vol 8. issue 1. 2013-07-01. PMID:23308105. |
effect of aripiprazole on mismatch negativity (mmn) in schizophrenia. |
2013-07-01 |
2023-08-12 |
Not clear |